| Literature DB >> 26395877 |
Bernardo Bello-Ortí1, Kate J Howell2, Alexander W Tucker3, Duncan J Maskell4, Virginia Aragon5.
Abstract
Haemophilus parasuis is a common inhabitant of the upper respiratory tract of pigs, and the causative agent of Glässer's disease. This disease is characterized by polyserositis and arthritis, produced by the severe inflammation caused by the systemic spread of the bacterium. After an initial colonization of the upper respiratory tract, H. parasuis enters the lung during the early stages of pig infection. In order to study gene expression at this location, we sequenced the ex vivo and in vivo H. parasuis Nagasaki transcriptome in the lung using a metatranscriptomic approach. Comparison of gene expression under these conditions with that found in conventional plate culture showed generally reduced expression of genes associated with anabolic and catabolic pathways, coupled with up-regulation of membrane-related genes involved in carbon acquisition, iron binding and pathogenesis. Some of the up-regulated membrane genes, including ABC transporters, virulence-associated autotransporters (vtaAs) and several hypothetical proteins, were only present in virulent H. parasuis strains, highlighting their significance as markers of disease potential. Finally, the analysis also revealed the presence of numerous antisense transcripts with possible roles in gene regulation. In summary, this data sheds some light on the scarcely studied in vivo transcriptome of H. parasuis, revealing nutritional virulence as an adaptive strategy for host survival, besides induction of classical virulence factors.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26395877 PMCID: PMC4580352 DOI: 10.1186/s13567-015-0225-9
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Figure 1MA plots generated by EdgeR. Transcript expression profiles in the two comparisons performed: ex vivo vs plate culture (A) and in vivo vs plate culture (B). For each gene, log2(fold change) between the two conditions is plotted (M, y axis) against the gene’s log2(average expression) in the two samples (A, x axis). Horizontal lines indicate 2-fold changes. Grey dots highlight the genes at 5% FDR.
Genes whose expression was validated using RT-qPCR with purified RNA from Nagasaki recovered after 2 h incubation in lung explants (ex vivo), 2 h after intratracheal infection (in vivo) and lung samples from a time-course intranasal infection (1 dpi, 2 dpi and 3 dpi)
|
|
|
| ᅟ |
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| ||
|
|
| ||||||||
| HPNK_10441 | Virulence factor | ND2 | 4.8 | 4.2 | 3.7 | 4.6 | ABC transporter, permease protein | 4.2 | 4.0 |
| HPNK_06205 | Virulence factor | ND | 4.9 | 4.6 | 2.9 | 4.9 | Hypothetical protein | 2.1 | 6.0 |
| HPNK_09829 | Virulence factor | ND | 3.6 | 4.1 | 1.4 | 3.3 | Hypothetical protein | 5.2 | 2.8 |
| HPNK_10446 | Virulence factor | ND | 3.3 | 3.5 | 2.4 | 3.1 | Hypothetical protein | 3.1 | 5.5 |
| HPNK_11461 | Virulence factor | ND | 5.2 | 2.1 | 2.2 | 2.9 | Hypothetical protein | 1.8 | 3.8 |
| HPNK_06565 | Virulence factor | ND | 5.4 | HCT 3 | HCT | 3.7 | Na+/H+ antiporter NhaC | 2.3 | 3.3 |
| HPNK_01698 | Virulence factor | ND | 4.1 | 3.8 | 3.2 | 3.0 | VtaA2 | 1.6 | 3.1 |
| HPNK_03728 | Key pathway | 2.3 | 5.0 | ND | ND | ND | 6-pyruvoyl tetrahydrobiopterin synthase | 2.6 | 1.7 |
| HPNK_08953 | Key pathway | 4.3 | 2.4 | ND | ND | ND | ABC transporter inner membrane subunit | 7.3 | 3.4 |
| HPNK_06845 | Key pathway | 3.9 | 5.3 | ND | ND | ND | Anthranilate synthase component II | 9.1 | 1.8 |
| HPNK_01064 | Key pathway | 1.3 | 5.9 | ND | ND | ND | Heme exporter protein D | 1.2 | 2.0 |
| HPNK_10256 | Key pathway | −2.8 | 0.6 | ND | ND | ND | PTS mannose-specific transporter subunit | −3.2 | −1.9 |
| HPNK_05784 | Key pathway | −4.2 | −0.6 | ND | ND | ND | Type II citrate synthase | −4.7 | −3.4 |
| HPNK_02274 | Reference | ND | - | - | - | - | BirA repressor | −0.1 | −0.1 |
| HPNK_07913 | Reference | ND | - | - | - | - | MurE ligase | −0.1 | 0.1 |
| HPNK_00732 | Reference | - | ND | ND | ND | ND | 50S ribosomal protein L5 | −0.5 | −1.7 |
| HPNK_07703 | Reference | - | ND | ND | ND | ND | Translocation protein TolB | −0.2 | −0.4 |
| HPNK_09689 | Reference | - | ND | ND | ND | ND | 50S ribosomal protein L2 | 0.7 | −0.6 |
| HPNK_01728 | Reference | - | ND | ND | ND | ND | pyruvate dehydrogenase subunit E1 | 0.0 | −1.7 |
1log2 fold changes; 2Not determined; 3the gene was amplified but the high CT values obtained were not sufficient to calculate differential expression.
Results of the comparison between the sets of differentially expressed genes (DEG) and enriched Gene Ontology (GO) terms between Nagasaki recovered after 2 h incubation in lung explants (ex vivo) or recovered 2 h after intratracheal infection (in vivo)
|
|
|
|
|
|---|---|---|---|
| DEGs UP | 273 | 120 | 249 |
| DEGs DOWN | 273 | 99 | 74 |
| GOs UP | 74 | 5 | 46 |
| GOs DOWN | 68 | 115 | 102 |
Figure 2Expression of surface CD163, SLAI, SLAII and sialoadhesin on alveolar macrophages. The pig was intratracheally inoculated with H. parasuis strain Nagasaki (black bars). Infection was allowed to proceed during 2 h, when the animal was euthanized and alveolar macrophages were obtained from the lung by lavage. A control non-infected pig was included as the control (gray bars). Level of expression of the surface markers was measured with specific monoclonal antibodies by flow cytometry. Results (mean of the x-mean ± standard deviation) are representative of two independent analyses run with duplicate samples.
List of up-regulated membrane genes ( < 0.05) unique of virulent strains (V) or present at most in one non-virulent strain (one NV)
|
|
|
|
|
|---|---|---|---|
| HPNK_10441 | in vivo/ex vivo | ABC transporter, permease protein | Unique V |
| HPNK_03268 | in vivo | Bacteriophage tail protein GPT | Unique V |
| HPNK_04602 | ex vivo | CDP-diglyceride pyrophosphorylase | Unique V |
| HPNK_01144 | ex vivo | Copper-transporting P-type ATPase | Unique V |
| HPNK_07008 | ex vivo | Exonuclease III | Unique V |
| HPNK_00812 | in vivo/ex vivo | Hypothetical protein | One NV |
| HPNK_06205 | in vivo/ex vivo | Hypothetical protein | Unique V |
| HPNK_09829 | in vivo/ex vivo | Hypothetical protein | Unique V |
| HPNK_10446 | in vivo/ex vivo | Hypothetical protein | Unique V |
| HPNK_09189 | ex vivo | Hypothetical protein | One NV |
| HPNK_00632 | ex vivo | Hypothetical protein | Unique V |
| HPNK_00572 | in vivo | Hypothetical protein | Unique V |
| HPNK_05179 | in vivo | Hypothetical protein | Unique V |
| HPNK_00277 | in vivo | Hypothetical protein | Unique V |
| HPNK_08083 | in vivo | Hypothetical protein | One NV |
| HPNK_10351 | in vivo | Hypothetical protein | Unique V |
| HPNK_00312 | in vivo | Hypothetical protein | One NV |
| HPNK_11566 | in vivo | Hypothetical protein | One NV |
| HPNK_11461 | in vivo | Hypothetical protein | One NV |
| HPNK_04137 | in vivo | Hypothetical protein | One NV |
| HPNK_04889 | in vivo | ISAs1 family transposase | One NV |
| HPNK_00080 | in vivo | ISAs1 family transposase | One NV |
| HPNK_04984 | in vivo | ISAs1 family transposase | One NV |
| HPNK_06565 | in vivo/ex vivo | Na+/H+ antiporter NhaC | Unique V |
| HPNK_11451 | ex vivo | Phage-like minor tail protein | One NV |
| HPNK_07568 | ex vivo | Polysaccharide biosynthesis protein CapD | Unique V |
| HPNK_05239 | in vivo | putative iron compound ABC transporter permease | Unique V |
| HPNK_00090 | in vivo | Putative phage DNA replication protein O | One NV |
| HPNK_09849 | in vivo | Polyketide cyclase SnoaL-like domain protein | Unique V |
| HPNK_07393 | in vivo | Tetratricopeptide-like helical domain protein | Unique V |
| HPNK_07408 | in vivo | Sel1 domain protein, repeat-containing protein | Unique V |
| HPNK_07403 | in vivo | Sel1 domain protein, repeat-containing protein | Unique V |
| HPNK_00210 | in vivo/ex vivo | Transposase, Mutator family protein | One NV |
| HPNK_09439 | in vivo/ex vivo | VtaA1 | Unique V |
| HPNK_01479 | in vivo/ex vivo | VtaA11 | Unique V |
| HPNK_01698 | in vivo/ex vivo | VtaA2 | Unique V |
| HPNK_07258 | in vivo | VtaA3 | Unique V |
| HPNK_10146 | in vivo/ex vivo | VtaA4 | Unique V |
| HPNK_02582 | in vivo/ex vivo | VtaA7 | Unique V |
| HPNK_01967 | in vivo | VtaA8 | Unique V |
| HPNK_10812 | in vivo | VtaA9 | Unique V |
1up-regulated in vivo, ex vivo or in both samples (in vivo/ex vivo).
Figure 3Validation of antisense RNA (asRNA) expressed in vivo and in plate culture. A Electrophoresis gel of four asRNA amplified by RT-PCR showing amplification results for RNA purified from plate culture with RT step (P+), plate culture without RT step (P-), 2 h in vivo sample with RT (V+) or without RT step (V-). Genomic DNA was included as the positive control (C+) and water as the negative control (C-). B Venn diagram showing overlapping Gene Ontology (GO) enriched terms for up- and down-regulated asRNA or sense RNA at 5% FDR.